NCT02554552

Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee

A Multicenter, Randomized, Double-blinded, Parallel, Placebo-controlled, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular YY1201 Once in the Treatment of Patients With Osteoarthritis of the Knee

• Status: Withdrawn
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Yooyoung Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Accepted

Summary

This is a multicenter, randomized, double-blinded, parallel, placebo-controlled, phase I/IIa clinical trial of YY1201 for treatment of osteoarthritis of the knee.

Detailed description

phase I/IIa clinical trial of YY1201 for treatment of osteoarthritis of the knee

Conditions

• Osteoarthritis, Knee

Interventions

Type	Name	Description
DRUG	YY1201 2ml	YY1201 2ml
DRUG	Placebo 2ml	phosphate buffered saline 2ml
DRUG	YY1201 3ml	YY1201 2ml
DRUG	Placebo 3ml	phosphate buffered saline 3ml

Timeline

• Start date: 2015-09-01
• Primary completion: 2016-10-01
• Completion: 2016-10-01
• First posted: 2015-09-18
• Last updated: 2016-11-17

Locations

1 site across 1 country: South Korea